Study to investigate the safety, tolerability and pharmacokinetics of single doses of AZD8566.

Study identifier:D1320C00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Randomised, Double Blind, Placebo-controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Oral Doses of AZD8566 in Healthy Volunteers

Medical condition

Healthy Volunteer

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD8566, Placebo

Sex

All

Actual Enrollment

108

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 01 Aug 2008
Primary Completion Date: 01 Feb 2009
Study Completion Date: 01 Feb 2009

Study design

Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Basic Science

Verification:

Verified 01 Apr 2009 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria